Trial intelligence / Profile preview

Phase 3 open-label AA4500 for Dupuytren's contracture

2006-006143-31Phase 3Completed

Sponsor
Auxilium UK Limited
Start
Sep 2007
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Auxilium UK Limited. Primary endpoint: Clinical success. Started Sep 2007; status: completed.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's contracture

Beyond the preview

Go deeper on 2006-006143-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006143-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call